VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization
VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization GlobeNewswire January 08, 2026 VarmX and Rentschler Biopharma expand collaboration from early development to lateâ€'stage and commercial manufacturing of VMX-C001 VMXâ€'C001 builds on strong regulatory momentum, including FDA Fast Track Designation and PMDA Phase 1 waiver, as it progresses toward […]